CRISPincette™ LUNG

- CRISPincette™ LUNG s an NGS (Next-Generation Sequencing)-based NSCLC (Non-Small Cell Lung Cancer) diagnostic panel with GeneCker’s ultra-precision CRISPR/Cas9 system. - Using an ultra-precision CRISPR/Cas9 system, cancer can be diagnosed with small amounts of blood or tissue, FFPE by improving the detection limits of genetic variation. - Instead of complex surgical methods, simple blood collection can swiftly and accurately analyze mutant DNA, and periodic monitoring tests are also possible with simple procedures. • Key Features ▸ Diagnostic kit based on NGS - NGS panel diagnostic kit to detect major cancer-related mutations ▸ Convenience of diagnosis - Improve diagnostic convenience using cfDNA in the blood or gDNA in Tissue, FFPE - Suitable for safe and periodic monitoring checks ▸ CRISPR/Cas9 system - Amplify only mutated regions after removing wild-type DNA with ultra-precision genetic scissors ▸ High sensitivity - Improved detection limits using ultra-precision genetic scissors (≥0.25% VAF) ▸ Reasonable cost - Increased number of samples from one analysis compared to existing NGS panels ▸ All-in-one platform - Integrated systems from diagnosis to analysis at once